Erectile dysfunction correlates with left ventricular function and precedes cardiovascular events in cardiovascular high-risk patients

International Journal of Clinical Practice

Volumn 61, Issue 3, 2007, Pages 361-366

  Baumhäkel, Magnus ^a   Bohm M ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ENDOTHELIAL DYSFUNCTION; ERECTILE DYSFUNCTION; HEART EJECTION FRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HIGH RISK PATIENT; HUMAN; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; HUMANS; IMPOTENCE, VASCULOGENIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSTATISM; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33847069197     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2006.01274.x     Document Type: Article

References (29)

1. National Institutes of Health Consensus Statement. Impotence 1992; 10: 1.
2. Kinsey AC, Pomeroy W, Martin CE. (eds) (1948) Age and Sexual outlet. In. Sexual Behaviour in the Human Male. pp. 218-62. W. B. Saunders Co., Philadelphia.
3. Virag R, Bouilly P, Frydman D. Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men. Lancet 1985; 1: 181-4.
4. Grimm RH Jr, Grandits GA, Prineas RJ et al. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS). Hypertension 1997; 29: 8-14.
5. Feldman HA, Goldstein I, Hatzichristou DG et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54-61.
6. Braun M, Wassmer G, Klotz T et al. Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'. Int J Impot Res 2000; 12: 305-11.
7. Bolad I, Delafontaine P. Endothelial dysfunction: its role in hypertensive coronary disease. Curr Opin Cardiol 2005; 20: 270-4.
8. Yavuzgil O, Altay B, Zoghi M et al. Endothelial function in patients with vasculogenic erectile dysfunction. Int J Cardiol 2005; 103: 19-26.
9. Lopez Farre A, Casado S. Heart failure, redox alterations, and endothelial dysfunction. Hypertension 2001; 38: 1400-5.
10. Katz SD, Biasucci L, Sabba C et al. Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. J Am Coll Cardiol 1992; 19: 918-25.
11. Rickham PP. Human Experimentation. Code of Ethics of the World Medical Association. Declaration of Helsinki. Br Med J 1964; 5402: 177.
12. Rosen RC, Cappelleri JC, Smith MD et al. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999; 11: 319-26.
13. Rhoden EL, Teloken C, Sogari PR et al. The use of the simplified International Index of Erectile Function (IIEF-5) as a diagnostic tool to study the prevalence of erectile dysfunction. Int J Impot Res 2002; 14: 245-50.
14. Russell ST, Khandheria BK, Nehra A. Erectile dysfunction and cardiovascular disease. Mayo Clin Proc 2004; 79: 782-94.
15. Feldman HA, Johannes CB, Derby CA et al. Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study. Prev Med 2000; 30: 328-38.
16. Walczak MK, Lokhandwala N, Hodge MB et al. Prevalence of cardiovascular risk factors in erectile dysfunction. J Gend Specif Med 2002; 5: 19-24.
17. Greenstein A, Chen J, Miller H et al. Does severity of ischemic coronary disease correlate with erectile function? Int J Impot Res 1997; 9: 123-6.
18. Ip JH, Fuster V, Badimon L et al. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol 1990; 15: 1667-87.
19. Lefer DJ, Granger DN. Oxidative stress and cardiac disease. Am J Med 2000; 109: 315-23.
20. Barksdale JD, Gardner SF. The impact of first-line antihypertensive drugs on erectile dysfunction. Pharmacotherapy 1999; 19: 573-81.
21. Smith PJ, Talbert RL. Sexual dysfunction with antihypertensive and antipsychotic agents. Clin Pharm 1986; 5: 373-84.
22. Muller SC, El-Damanhoury H, Ruth J et al. Hypertension and impotence. Eur Urol 1991; 19: 29-34.
23. Fogari R, Zoppi A, Corradi L et al. Sexual function in hypertensive males treated with lisinopril or atenolol: a cross-over study. Am J Hypertens 1998; 11: 1244-7.
24. Dorrance AM, Lewis RW, Mills TM. Captopril treatment reverses erectile dysfunction in male Stroke Prone Spontaneously Hypertensive Rats. Int J Impot Res 2002; 14: 494-7.
25. Dusing R. Effect of the angiotensin II antagonist valsartan on sexual function in hypertensive men. Blood Press Suppl 2003; 2: 29-34.
26. Fogari R, Zoppi A, Poletti L et al. Sexual activity in hypertensive men treated with valsartan or carvedilol: a crossover study. Am J Hypertens 2001; 14: 27-31.
27. Schwarz ER, Rastogi S, Kapur V et al. Erectile dysfunction in heart failure patients. J Am Coll Cardiol 2006; 48: 1111-9.
28. Min JK, Williams KA, Okwuosa TM et al. Prediction of coronary heart disease by erectile dysfunction in men referred for nuclear stress testing. Arch Intern Med 2006; 166: 201-6.
29. Jaarsma T, Dracup K, Walden J et al. Sexual function in patients with advanced heart failure. Heart Lung 1996; 25: 262-70.